We have read with interest the paper by Shin et al. that demonstrates that intracoronary delivery of mitochondria affords protection against ischemiareperfusion injury in pigs (1). This study is presented as a necessary step toward the assessment of a similar approach in human subjects who experience a myocardial infarction (MI), in whom intracoronary injection of mitochondria could prevent further myocardial necrosis following percutaneous revascularization of the culprit lesion (1). In this study, the reperfusion and intracoronary delivery of mitochondria occurred after a 30-min occlusion of the left anterior descending (LAD) artery. According to the ischemic cascade, cardiomyocyte necrosis will start after 30-min ischemia and only in the core of the hypoperfused area. Furthermore, a 30-min interval between first medical contact (FMC) and reperfusion is implausible in patients with ST-segment elevation MI (STEMI), in whom a much longer interval (<90 min between FMC and reperfusion) is deemed optimal (2).
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